Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The effect of transversus abdominal plane block on maternal-infant bonding after cesarean delivery: A randomized controlled study.

Created on 05 Aug 2026

Authors

Nezir Yilmaz, Hakan Haydarlar, Zeliha Bozkurt, Fatih Ertaş, Dilara Doymaz, Damla Yilmaz

Published in

Saudi journal of anaesthesia. Volume 20. Issue 3. Pages 519-524. Epub Jul 02, 2026.

Abstract

Effective postoperative analgesia after cesarean delivery is essential for early functional recovery. Ultrasound-guided transversus abdominis plane (TAP) block reduces postoperative pain and opioid consumption; however, its effects beyond analgesia remain unclear.
To evaluate the effects of TAP block on postoperative pain, maternal self-efficacy, and early recovery after elective cesarean delivery.
This prospective randomized study was conducted at a tertiary care center between December 2024 and March 2025.
Women undergoing elective cesarean section under spinal anesthesia were randomized to receive either bilateral ultrasound-guided TAP block (20 mL of 0.25% bupivacaine per side) or standard analgesia. Maternal self-efficacy was assessed at 48 hours postpartum using the Parent Self-efficacy Scale. Secondary outcomes included postoperative pain scores, time to first breastfeeding and mobilization, rescue analgesic use, neonatal caregiving duration within 24 hours, and length of hospital stay.
Appropriate parametric or non-parametric tests were applied, with P < 0.05 considered statistically significant.
A total of 128 patients completed the study. The TAP block group showed significantly lower pain scores, reduced rescue analgesic requirements, earlier breastfeeding and mobilization, longer neonatal caregiving duration, shorter hospital stay, and higher maternal self-efficacy scores (P < 0.05).
Ultrasound-guided TAP block provides effective analgesia and supports early functional recovery after cesarean delivery, with additional benefits on maternal self-efficacy.

PMID:
42553979
Bibliographic data and abstract were imported from PubMed on 05 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement